$1.14
0.000.00%
Pre-Market: 4:24 PM EDT
Comments
Loading...
Standard BioTools Analyst Ratings and Price Targets | NASDAQ:LAB | Benzinga
Standard BioTools Inc has a consensus price target of $2.88 based on the ratings of 3 analysts. The high is $3.25 issued by Jefferies on April 4, 2024. The low is $2.5 issued by TD Cowen on October 31, 2024. The 3 most-recent analyst ratings were released by TD Cowen on October 31, 2024, August 1, 2024, and April 16, 2024, respectively. With an average price target of $2.92 between TD Cowen, there's an implied 155.85% upside for Standard BioTools Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Jefferies
1calculated from analyst ratings
Analyst Ratings for Standard BioTools
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | Buy Now | — | Keybanc | Paul Knight53% | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 10/31/2024 | Buy Now | 119.3% | TD Cowen | Daniel Brennan46% | $2.75 → $2.5 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 141.23% | TD Cowen | Daniel Brennan46% | $3.5 → $2.75 | Maintains | Buy | Get Alert |
| 04/16/2024 | Buy Now | 207.02% | TD Cowen | Daniel Brennan46% | → $3.5 | Initiates | → Buy | Get Alert |
| 04/04/2024 | Buy Now | 185.09% | Jefferies | Matthew Stanton22% | → $3.25 | Initiates | → Buy | Get Alert |
| 07/12/2023 | Buy Now | 250.88% | Keybanc | Paul Knight53% | → $4 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Standard BioTools (LAB) stock?
The latest price target for Standard BioTools (NASDAQ:LAB) was reported by Keybanc on February 27, 2025. The analyst firm set a price target for $0.00 expecting LAB to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Standard BioTools (LAB)?
The latest analyst rating for Standard BioTools (NASDAQ:LAB) was provided by Keybanc, and Standard BioTools downgraded their sector weight rating.
When was the last upgrade for Standard BioTools (LAB)?
There is no last upgrade for Standard BioTools
When was the last downgrade for Standard BioTools (LAB)?
The last downgrade for Standard BioTools Inc happened on February 27, 2025 when Keybanc changed their price target from N/A to N/A for Standard BioTools Inc.
When is the next analyst rating going to be posted or updated for Standard BioTools (LAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Standard BioTools, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Standard BioTools was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
Is the Analyst Rating Standard BioTools (LAB) correct?
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a downgraded with a price target of $0.00 to $0.00. The current price Standard BioTools (LAB) is trading at is $1.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.